Real-world evidence: What is it and why does it matter to pharmacists?

Clinical Epidemiology and Global Health, 2023

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1016/j.cegh.2023.101229
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Real-world evidence (RWE) is the term used to describe data that is collected from real-world sources outside of randomized controlled trials (RCTs). These sources can include electronic health records, claims data, patient registries, and observational studies. The use of RWE has grown in popularity in recent years to fill gaps in our understanding of the effectiveness and safety of healthcare interventions.1 While RWE does not replace well-designed RCTs, it plays an increasingly important role in clinical decision-making and health care policy because it provides additional data that may not be captured in an RCT, such as off-label uses, real-world prescribing patterns, rare or idiosyncratic adverse events, and cost-effectiveness.